Organogenesis Holdings (ORGO) Net Cash Flow (2016 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Net Cash Flow of -$2.2 million for Q1 2026, up 91.29% year-over-year from -$1.2 million in Q1 2025, and down 107.45% quarter-over-quarter from $30.0 million in Q4 2025.
Organogenesis Holdings (ORGO) Net Cash Flow (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Net Cash Flow history runs 11 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 91.29% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$18.4 million (down 187.01% YoY), while the FY2025 annual figure was -$41.8 million, down 231.46% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$2.2 million, down from $30.0 million in the prior quarter.
- The five-year high for Net Cash Flow was $41.2 million in Q4 2024, with the low at -$36.8 million in Q2 2025.
- The 5-year median for Net Cash Flow is -$2.2 million (2026), against an average of -$1.3 million.
- The sharpest annual moves came in 2024 and 2025: Net Cash Flow soared 1116.13% in 2024, then sank 3353.67% in 2025.
- Organogenesis Holdings' Net Cash Flow stood at -$4.7 million in 2022, then jumped by 216.53% to $5.5 million in 2023, then soared by 647.78% to $41.2 million in 2024, then dropped by 27.33% to $30.0 million in 2025, then plunged by 107.45% to -$2.2 million in 2026.
- Business Quant data shows ORGO's Net Cash Flow at -$2.2 million in Q1 2026, $30.0 million in Q4 2025, and -$9.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Organogenesis Holdings | 229.04 Mn | 182.20 Mn | 20.08 Mn | -45.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -45.26 Mn |
| Jun 30, 2026 | -45.26 Mn |
| Mar 31, 2026 | -2.23 Mn |
| Mar 31, 2026 | -2.23 Mn |
| Dec 31, 2025 | 29.96 Mn |
| Dec 31, 2025 | 29.96 Mn |
| Sep 30, 2025 | -9.36 Mn |
| Sep 30, 2025 | -9.36 Mn |
| Jun 30, 2025 | -36.80 Mn |
| Jun 30, 2025 | -36.80 Mn |
| Mar 31, 2025 | -25.62 Mn |
| Mar 31, 2025 | -25.62 Mn |
| Dec 31, 2024 | 41.23 Mn |
| Dec 31, 2024 | 41.23 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | -14.99 Mn |
| Mar 31, 2024 | -14.99 Mn |